Global Esketamine Market Growth 2025-2031

December 2025 | 79 pages | ID: GE4086A1DBF2EN
LP Information

Abstracts

The global Esketamine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Esketamine is a medication used as a general anesthetic and for treatment-resistant depression.

United States market for Esketamine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Esketamine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Esketamine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Esketamine players cover Merck, Medkoo, Endo International, Janssen Pharmaceutica, PFIZER, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Esketamine Industry Forecast” looks at past sales and reviews total world Esketamine sales in 2024, providing a comprehensive analysis by region and market sector of projected Esketamine sales for 2025 through 2031. With Esketamine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Esketamine industry.

This Insight Report provides a comprehensive analysis of the global Esketamine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Esketamine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Esketamine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Esketamine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Esketamine.

This report presents a comprehensive overview, market shares, and growth opportunities of Esketamine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Oral Medications
• Injection
• Nasal Spray

Segmentation by Application:

• General Anesthetic
• Treatment-resistant Depression

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Merck
• Medkoo
• Endo International
• Janssen Pharmaceutica
• PFIZER

Key Questions Addressed in this Report

What is the 10-year outlook for the global Esketamine market?

What factors are driving Esketamine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Esketamine market opportunities vary by end market size?

How does Esketamine break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Esketamine Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Esketamine by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Esketamine by Country/Region, 2020, 2024 & 2031
2.2 Esketamine Segment by Type
  2.2.1 Oral Medications
  2.2.2 Injection
  2.2.3 Nasal Spray
2.3 Esketamine Sales by Type
  2.3.1 Global Esketamine Sales Market Share by Type (2020-2025)
  2.3.2 Global Esketamine Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Esketamine Sale Price by Type (2020-2025)
2.4 Esketamine Segment by Application
  2.4.1 General Anesthetic
  2.4.2 Treatment-resistant Depression
2.5 Esketamine Sales by Application
  2.5.1 Global Esketamine Sale Market Share by Application (2020-2025)
  2.5.2 Global Esketamine Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Esketamine Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Esketamine Breakdown Data by Company
  3.1.1 Global Esketamine Annual Sales by Company (2020-2025)
  3.1.2 Global Esketamine Sales Market Share by Company (2020-2025)
3.2 Global Esketamine Annual Revenue by Company (2020-2025)
  3.2.1 Global Esketamine Revenue by Company (2020-2025)
  3.2.2 Global Esketamine Revenue Market Share by Company (2020-2025)
3.3 Global Esketamine Sale Price by Company
3.4 Key Manufacturers Esketamine Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Esketamine Product Location Distribution
  3.4.2 Players Esketamine Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ESKETAMINE BY GEOGRAPHIC REGION

4.1 World Historic Esketamine Market Size by Geographic Region (2020-2025)
  4.1.1 Global Esketamine Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Esketamine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Esketamine Market Size by Country/Region (2020-2025)
  4.2.1 Global Esketamine Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Esketamine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Esketamine Sales Growth
4.4 APAC Esketamine Sales Growth
4.5 Europe Esketamine Sales Growth
4.6 Middle East & Africa Esketamine Sales Growth

5 AMERICAS

5.1 Americas Esketamine Sales by Country
  5.1.1 Americas Esketamine Sales by Country (2020-2025)
  5.1.2 Americas Esketamine Revenue by Country (2020-2025)
5.2 Americas Esketamine Sales by Type (2020-2025)
5.3 Americas Esketamine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Esketamine Sales by Region
  6.1.1 APAC Esketamine Sales by Region (2020-2025)
  6.1.2 APAC Esketamine Revenue by Region (2020-2025)
6.2 APAC Esketamine Sales by Type (2020-2025)
6.3 APAC Esketamine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Esketamine by Country
  7.1.1 Europe Esketamine Sales by Country (2020-2025)
  7.1.2 Europe Esketamine Revenue by Country (2020-2025)
7.2 Europe Esketamine Sales by Type (2020-2025)
7.3 Europe Esketamine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Esketamine by Country
  8.1.1 Middle East & Africa Esketamine Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Esketamine Revenue by Country (2020-2025)
8.2 Middle East & Africa Esketamine Sales by Type (2020-2025)
8.3 Middle East & Africa Esketamine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Esketamine
10.3 Manufacturing Process Analysis of Esketamine
10.4 Industry Chain Structure of Esketamine

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Esketamine Distributors
11.3 Esketamine Customer

12 WORLD FORECAST REVIEW FOR ESKETAMINE BY GEOGRAPHIC REGION

12.1 Global Esketamine Market Size Forecast by Region
  12.1.1 Global Esketamine Forecast by Region (2026-2031)
  12.1.2 Global Esketamine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Esketamine Forecast by Type (2026-2031)
12.7 Global Esketamine Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Merck
  13.1.1 Merck Company Information
  13.1.2 Merck Esketamine Product Portfolios and Specifications
  13.1.3 Merck Esketamine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Merck Main Business Overview
  13.1.5 Merck Latest Developments
13.2 Medkoo
  13.2.1 Medkoo Company Information
  13.2.2 Medkoo Esketamine Product Portfolios and Specifications
  13.2.3 Medkoo Esketamine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Medkoo Main Business Overview
  13.2.5 Medkoo Latest Developments
13.3 Endo International
  13.3.1 Endo International Company Information
  13.3.2 Endo International Esketamine Product Portfolios and Specifications
  13.3.3 Endo International Esketamine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Endo International Main Business Overview
  13.3.5 Endo International Latest Developments
13.4 Janssen Pharmaceutica
  13.4.1 Janssen Pharmaceutica Company Information
  13.4.2 Janssen Pharmaceutica Esketamine Product Portfolios and Specifications
  13.4.3 Janssen Pharmaceutica Esketamine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Janssen Pharmaceutica Main Business Overview
  13.4.5 Janssen Pharmaceutica Latest Developments
13.5 PFIZER
  13.5.1 PFIZER Company Information
  13.5.2 PFIZER Esketamine Product Portfolios and Specifications
  13.5.3 PFIZER Esketamine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 PFIZER Main Business Overview
  13.5.5 PFIZER Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Esketamine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Esketamine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oral Medications
Table 4. Major Players of Injection
Table 5. Major Players of Nasal Spray
Table 6. Global Esketamine Sales by Type (2020-2025) & (K Units)
Table 7. Global Esketamine Sales Market Share by Type (2020-2025)
Table 8. Global Esketamine Revenue by Type (2020-2025) & ($ million)
Table 9. Global Esketamine Revenue Market Share by Type (2020-2025)
Table 10. Global Esketamine Sale Price by Type (2020-2025) & (USD/Unit)
Table 11. Global Esketamine Sale by Application (2020-2025) & (K Units)
Table 12. Global Esketamine Sale Market Share by Application (2020-2025)
Table 13. Global Esketamine Revenue by Application (2020-2025) & ($ million)
Table 14. Global Esketamine Revenue Market Share by Application (2020-2025)
Table 15. Global Esketamine Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Esketamine Sales by Company (2020-2025) & (K Units)
Table 17. Global Esketamine Sales Market Share by Company (2020-2025)
Table 18. Global Esketamine Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Esketamine Revenue Market Share by Company (2020-2025)
Table 20. Global Esketamine Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Esketamine Producing Area Distribution and Sales Area
Table 22. Players Esketamine Products Offered
Table 23. Esketamine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Esketamine Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Esketamine Sales Market Share Geographic Region (2020-2025)
Table 28. Global Esketamine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Esketamine Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Esketamine Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Esketamine Sales Market Share by Country/Region (2020-2025)
Table 32. Global Esketamine Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Esketamine Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Esketamine Sales by Country (2020-2025) & (K Units)
Table 35. Americas Esketamine Sales Market Share by Country (2020-2025)
Table 36. Americas Esketamine Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Esketamine Sales by Type (2020-2025) & (K Units)
Table 38. Americas Esketamine Sales by Application (2020-2025) & (K Units)
Table 39. APAC Esketamine Sales by Region (2020-2025) & (K Units)
Table 40. APAC Esketamine Sales Market Share by Region (2020-2025)
Table 41. APAC Esketamine Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Esketamine Sales by Type (2020-2025) & (K Units)
Table 43. APAC Esketamine Sales by Application (2020-2025) & (K Units)
Table 44. Europe Esketamine Sales by Country (2020-2025) & (K Units)
Table 45. Europe Esketamine Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Esketamine Sales by Type (2020-2025) & (K Units)
Table 47. Europe Esketamine Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Esketamine Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Esketamine Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Esketamine Sales by Type (2020-2025) & (K Units)
Table 51. Middle East & Africa Esketamine Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Esketamine
Table 53. Key Market Challenges & Risks of Esketamine
Table 54. Key Industry Trends of Esketamine
Table 55. Esketamine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Esketamine Distributors List
Table 58. Esketamine Customer List
Table 59. Global Esketamine Sales Forecast by Region (2026-2031) & (K Units)
Table 60. Global Esketamine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Esketamine Sales Forecast by Country (2026-2031) & (K Units)
Table 62. Americas Esketamine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Esketamine Sales Forecast by Region (2026-2031) & (K Units)
Table 64. APAC Esketamine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Esketamine Sales Forecast by Country (2026-2031) & (K Units)
Table 66. Europe Esketamine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Esketamine Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Esketamine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Esketamine Sales Forecast by Type (2026-2031) & (K Units)
Table 70. Global Esketamine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Esketamine Sales Forecast by Application (2026-2031) & (K Units)
Table 72. Global Esketamine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Merck Basic Information, Esketamine Manufacturing Base, Sales Area and Its Competitors
Table 74. Merck Esketamine Product Portfolios and Specifications
Table 75. Merck Esketamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Merck Main Business
Table 77. Merck Latest Developments
Table 78. Medkoo Basic Information, Esketamine Manufacturing Base, Sales Area and Its Competitors
Table 79. Medkoo Esketamine Product Portfolios and Specifications
Table 80. Medkoo Esketamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Medkoo Main Business
Table 82. Medkoo Latest Developments
Table 83. Endo International Basic Information, Esketamine Manufacturing Base, Sales Area and Its Competitors
Table 84. Endo International Esketamine Product Portfolios and Specifications
Table 85. Endo International Esketamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Endo International Main Business
Table 87. Endo International Latest Developments
Table 88. Janssen Pharmaceutica Basic Information, Esketamine Manufacturing Base, Sales Area and Its Competitors
Table 89. Janssen Pharmaceutica Esketamine Product Portfolios and Specifications
Table 90. Janssen Pharmaceutica Esketamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Janssen Pharmaceutica Main Business
Table 92. Janssen Pharmaceutica Latest Developments
Table 93. PFIZER Basic Information, Esketamine Manufacturing Base, Sales Area and Its Competitors
Table 94. PFIZER Esketamine Product Portfolios and Specifications
Table 95. PFIZER Esketamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. PFIZER Main Business
Table 97. PFIZER Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Esketamine
Figure 2. Esketamine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Esketamine Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Esketamine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Esketamine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Esketamine Sales Market Share by Country/Region (2024)
Figure 10. Esketamine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Oral Medications
Figure 12. Product Picture of Injection
Figure 13. Product Picture of Nasal Spray
Figure 14. Global Esketamine Sales Market Share by Type in 2025
Figure 15. Global Esketamine Revenue Market Share by Type (2020-2025)
Figure 16. Esketamine Consumed in General Anesthetic
Figure 17. Global Esketamine Market: General Anesthetic (2020-2025) & (K Units)
Figure 18. Esketamine Consumed in Treatment-resistant Depression
Figure 19. Global Esketamine Market: Treatment-resistant Depression (2020-2025) & (K Units)
Figure 20. Global Esketamine Sale Market Share by Application (2024)
Figure 21. Global Esketamine Revenue Market Share by Application in 2025
Figure 22. Esketamine Sales by Company in 2025 (K Units)
Figure 23. Global Esketamine Sales Market Share by Company in 2025
Figure 24. Esketamine Revenue by Company in 2025 ($ millions)
Figure 25. Global Esketamine Revenue Market Share by Company in 2025
Figure 26. Global Esketamine Sales Market Share by Geographic Region (2020-2025)
Figure 27. Global Esketamine Revenue Market Share by Geographic Region in 2025
Figure 28. Americas Esketamine Sales 2020-2025 (K Units)
Figure 29. Americas Esketamine Revenue 2020-2025 ($ millions)
Figure 30. APAC Esketamine Sales 2020-2025 (K Units)
Figure 31. APAC Esketamine Revenue 2020-2025 ($ millions)
Figure 32. Europe Esketamine Sales 2020-2025 (K Units)
Figure 33. Europe Esketamine Revenue 2020-2025 ($ millions)
Figure 34. Middle East & Africa Esketamine Sales 2020-2025 (K Units)
Figure 35. Middle East & Africa Esketamine Revenue 2020-2025 ($ millions)
Figure 36. Americas Esketamine Sales Market Share by Country in 2025
Figure 37. Americas Esketamine Revenue Market Share by Country (2020-2025)
Figure 38. Americas Esketamine Sales Market Share by Type (2020-2025)
Figure 39. Americas Esketamine Sales Market Share by Application (2020-2025)
Figure 40. United States Esketamine Revenue Growth 2020-2025 ($ millions)
Figure 41. Canada Esketamine Revenue Growth 2020-2025 ($ millions)
Figure 42. Mexico Esketamine Revenue Growth 2020-2025 ($ millions)
Figure 43. Brazil Esketamine Revenue Growth 2020-2025 ($ millions)
Figure 44. APAC Esketamine Sales Market Share by Region in 2025
Figure 45. APAC Esketamine Revenue Market Share by Region (2020-2025)
Figure 46. APAC Esketamine Sales Market Share by Type (2020-2025)
Figure 47. APAC Esketamine Sales Market Share by Application (2020-2025)
Figure 48. China Esketamine Revenue Growth 2020-2025 ($ millions)
Figure 49. Japan Esketamine Revenue Growth 2020-2025 ($ millions)
Figure 50. South Korea Esketamine Revenue Growth 2020-2025 ($ millions)
Figure 51. Southeast Asia Esketamine Revenue Growth 2020-2025 ($ millions)
Figure 52. India Esketamine Revenue Growth 2020-2025 ($ millions)
Figure 53. Australia Esketamine Revenue Growth 2020-2025 ($ millions)
Figure 54. China Taiwan Esketamine Revenue Growth 2020-2025 ($ millions)
Figure 55. Europe Esketamine Sales Market Share by Country in 2025
Figure 56. Europe Esketamine Revenue Market Share by Country (2020-2025)
Figure 57. Europe Esketamine Sales Market Share by Type (2020-2025)
Figure 58. Europe Esketamine Sales Market Share by Application (2020-2025)
Figure 59. Germany Esketamine Revenue Growth 2020-2025 ($ millions)
Figure 60. France Esketamine Revenue Growth 2020-2025 ($ millions)
Figure 61. UK Esketamine Revenue Growth 2020-2025 ($ millions)
Figure 62. Italy Esketamine Revenue Growth 2020-2025 ($ millions)
Figure 63. Russia Esketamine Revenue Growth 2020-2025 ($ millions)
Figure 64. Middle East & Africa Esketamine Sales Market Share by Country (2020-2025)
Figure 65. Middle East & Africa Esketamine Sales Market Share by Type (2020-2025)
Figure 66. Middle East & Africa Esketamine Sales Market Share by Application (2020-2025)
Figure 67. Egypt Esketamine Revenue Growth 2020-2025 ($ millions)
Figure 68. South Africa Esketamine Revenue Growth 2020-2025 ($ millions)
Figure 69. Israel Esketamine Revenue Growth 2020-2025 ($ millions)
Figure 70. Turkey Esketamine Revenue Growth 2020-2025 ($ millions)
Figure 71. GCC Countries Esketamine Revenue Growth 2020-2025 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Esketamine in 2025
Figure 73. Manufacturing Process Analysis of Esketamine
Figure 74. Industry Chain Structure of Esketamine
Figure 75. Channels of Distribution
Figure 76. Global Esketamine Sales Market Forecast by Region (2026-2031)
Figure 77. Global Esketamine Revenue Market Share Forecast by Region (2026-2031)
Figure 78. Global Esketamine Sales Market Share Forecast by Type (2026-2031)
Figure 79. Global Esketamine Revenue Market Share Forecast by Type (2026-2031)
Figure 80. Global Esketamine Sales Market Share Forecast by Application (2026-2031)
Figure 81. Global Esketamine Revenue Market Share Forecast by Application (2026-2031)